UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030258 |
|---|---|
| Receipt number | R000034552 |
| Scientific Title | Dexmedetomidine and contrast induced nephropathy in patients undergoing coronary angiography using non-ionic contrast media. |
| Date of disclosure of the study information | 2017/12/04 |
| Last modified on | 2017/12/04 17:13:40 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Dexmedetomidine and contrast induced nephropathy in patients undergoing coronary angiography using non-ionic contrast media.
Acronym
Dexmedetomidine and contrast induced nephropathy
Scientific Title
Dexmedetomidine and contrast induced nephropathy in patients undergoing coronary angiography using non-ionic contrast media.
Scientific Title:Acronym
Dexmedetomidine and contrast induced nephropathy
Region
| Asia(except Japan) |
Condition
Condition
patients undergoing coronary angiography using non-ionic contrast media were recruited into the study
Classification by specialty
| Anesthesiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the efficacy of Dexmedetomidine administered preoperatively on contrast induced nephropathy
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the overall incidence of contrast induced nephropathy
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Medicine |
Interventions/Control_1
In group D, a loading dose of 0.001mg/kg dexmedetomidine given over 10 min followed by 0.0005mg/kg/h dexmedetomidine infusion.
Interventions/Control_2
In group S, patients recived the same amount of saline 0.9% infusion.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 70 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
adult patients undergoing coronary angiography were included in this study.
Key exclusion criteria
1,emergency cases;
2,patients with renal failure or diabetes mellitus, patients who were on nephrotoxic and vasoactive drugs simultaneously and patients with decompensated congestive heart failure;
3,patients who had been administered contrast media in the last 2 weeks;
Target sample size
60
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | chen jie |
Organization
Third Military Medical University
Division name
Department of Anaesthesiology, Southwest Hospital,
Zip code
Address
Gaotanyan road, Shapingba, Chongqing, China
TEL
+81-086-23-68754197
cjandsh@tmmu.edu.cn
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Chen jie |
Organization
Third Military Medical University
Division name
Department of Anaesthesiology, Southwest Hospital,
Zip code
Address
Gaotanyan road, Shapingba, Chongqing, China
TEL
+81-086-23-68754197
Homepage URL
cjandsh@tmmu.edu..cn
Sponsor or person
Institute
Department of Anaesthesiology, Southwest Hospital,
Institute
Department
Personal name
Funding Source
Organization
Department of Anaesthesiology, Southwest Hospital,
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 12 | Month | 04 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2017 | Year | 11 | Month | 14 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 11 | Month | 16 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 12 | Month | 04 | Day |
Last modified on
| 2017 | Year | 12 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034552
